Therapeutics

Tools

Back to the Top
Search By Attributes

Search Results

Name Synonyms FDA Status Company Target Type Therapy Type Condition Approved
For
AGB101 Levetiracetam,
Keppra
3, Discontinued AgeneBio, Inc. Amyloid-Related, Other Small Molecule Mild Cognitive Impairment, Parkinson's Disease Epilepsy and Partial Seizures in U.S., European Union, plus about 20 other countries
ALZT-OP1 Cromolyn sodium, Intal,
Ibuprofen
3 AZTherapies, Inc. Amyloid-Related, Inflammation Small Molecule Alzheimer's Disease
AZD3293 LY3314814,
BACE inhibitor
3 AstraZeneca, Eli Lilly & Co. Amyloid-Related Small Molecule Alzheimer's Disease
Aducanumab BIIB037 3 Biogen Amyloid-Related Immunotherapy (passive) Alzheimer's Disease
Azeliragon PF-04494700 ,
TTP488
3 Pfizer, TransTech Pharma, Inc., vTv Therapeutics LLC Amyloid-Related, Inflammation Small Molecule Alzheimer's Disease
Crenezumab MABT5102A ,
RG7412
3 Genentech, Hoffmann-La Roche Amyloid-Related Immunotherapy (passive) Alzheimer's Disease None
E2609 BACE inhibitor 3 Biogen, Eisai Co., Ltd. Amyloid-Related Small Molecule Alzheimer's Disease
Gantenerumab RO4909832,
RG1450
3 Chugai Pharmaceutical Co., Ltd., Hoffmann-La Roche Amyloid-Related Immunotherapy (passive) Alzheimer's Disease
Solanezumab LY2062430 3 Eli Lilly & Co. Amyloid-Related Immunotherapy (passive) Alzheimer's Disease None
Verubecestat MK-8931, MK-8931-009 ,
BACE inhibitor
3 Merck Amyloid-Related Small Molecule Alzheimer's Disease